Recruiting studies: C Difficile

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Stool Transplants to Treat Refractory Clostridium Difficile Colitis
Phase 2 · 1 location(s) · Duke University · NCT02127398 LMN-201 for Prevention of C. Difficile Infection Recurrence
Phase 2/Phase 3 · 16 location(s) · Lumen Bioscience, Inc. · NCT05330182 Lifestyle and Recurrent Clostridioides Difficile Infection (CDI)
NA · 1 location(s) · University of Michigan · NCT07613645 Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
Phase 2 · 2 location(s) · University of Virginia · NCT04305769 Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile
NA · 1 location(s) · Brigham and Women's Hospital · NCT05389904 Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Phase 2 · 116 location(s) · AstraZeneca · NCT07285213 Fecal Microbiota Transplantation for C Diff Infection
NA · 1 location(s) · Englewood Hospital and Medical Center · NCT01905709 C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
Phase N/A · 4 location(s) · Bactolife A/S · NCT07250724 VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Phase 3 · 215 location(s) · Vedanta Biosciences, Inc. · NCT06237452 Vancomycin Taper to Prevent Recurrent Clostridioides Difficile
Phase 3 · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT07328971 Secondary Prevention of Clostridioides Difficile Using Vancomycin
Phase 2/Phase 3 · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06979609

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.